Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot
2.3. Country Analysis
2.4. Key Growth Enablers
2.5. Key Challenges

3. Key Analytics
3.1. Porter’S Five Forces Analysis
3.1.1. Buyers Power
3.1.2. Suppliers Power
3.1.3. Substitution
3.1.4. New Entrants
3.1.5. Industry Rivalry
3.2. Impact Of Covid-19 On Alzheimer’S Disease Therapeutics And Diagnostics Market
3.3. Key Buying Criteria
3.4. Etymology Of Alzheimer’S Disease Therapeutics And Diagnostics Market
3.5. Supply Chain Analysis
3.6. Phases And Sternness Of Alzheimer’S Disease
3.7. Opportunity Matrix
3.8. Vendor Landscape
3.9. Key Market Trends

4. Market By Therapeutics And Diagnostics
4.1. Therapeutics
4.1.1. Therapeutics By Drugs
4.1.1.1. Marketed Drugs
4.1.1.2. Pipeline Drugs
4.1.2. Therapeutics By Disease Stage
4.1.2.1. Late Stage: Severe Ad
4.1.2.2. Early/Middle Stage: Mild To Moderate Ad
4.1.2.3. Prodromal Stage
4.1.3. Therapeutics By Generic And Branded
4.1.3.1. Branded
4.1.3.2. Generic
4.2. Diagnostics
4.2.1. Lumbar Puncture Test
4.2.2. Positron Emission Tomography
4.2.3. Electroencephalography
4.2.4. Magnetic Resonance Imaging
4.2.5. Computed Tomography
4.2.6. Blood Test
4.2.7. Other Diagnostics

5. Competitive Landscape
5.1. Key Strategic Developments
5.1.1. Mergers & Acquisitions
5.1.2. Product Launches & Developments
5.1.3. Partnerships, Contracts/Agreements & Collaborations
5.1.4. Business Expansions/ Approvals/ Announcements
5.2. Company Profiles
5.2.1. Baxter International Inc
5.2.2. Eisai Co Ltd
5.2.3. Eli Lilly & Company
5.2.4. Ge Healthcare
5.2.5. Lupin Limited
5.2.6. Novartis Ag
5.2.7. Sun Pharmaceuticals Industries Ltd



List of Figures

Figure 1: Porter’S Five Forces Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Market Trends
Figure 5: Japan Alzheimer’S Disease Therapeutics And Diagnostics Market, By Therapeutics, 2021-2026 ($ Million)
Figure 6: Japan Therapeutics Market, By Marketed Drugs, 2021-2026 ($ Million)
Figure 7: Japan Therapeutics Market, By Pipeline Drugs, 2021-2026 ($ Million)
Figure 8: Japan Therapeutics Market, By Late Stage, 2021-2026 ($ Million)
Figure 9: Japan Therapeutics Market, By Early/Middle Stage, 2021-2026 ($ Million)
Figure 10: Japan Therapeutics Market, By Prodromal Stage, 2021-2026 ($ Million)
Figure 11: Japan Therapeutics Market, By Branded, 2021-2026 ($ Million)
Figure 12: Japan Therapeutics Market, By Generic, 2021-2026 ($ Million)
Figure 13: Japan Alzheimer’S Disease Therapeutics And Diagnostics Market, By Diagnostics, 2021-2026 ($ Million)
Figure 14: Japan Diagnostics Market, By Lumbar Puncture Test, 2021-2026 ($ Million)
Figure 15: Japan Diagnostics Market, By Positron Emission Tomography, 2021-2026 ($ Million)
Figure 16: Japan Diagnostics Market, By Electroencephalography, 2021-2026 ($ Million)
Figure 17: Japan Diagnostics Market, By Magnetic Resonance Imaging, 2021-2026 ($ Million)
Figure 18: Japan Diagnostics Market, By Computed Tomography, 2021-2026 ($ Million)
Figure 19: Japan Diagnostics Market, By Blood Test, 2021-2026 ($ Million)
Figure 20: Japan Diagnostics Market, By Other Diagnostics, 2021-2026 ($ Million)

List of Tables

TABLE 1: MARKET SNAPSHOT - ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS
TABLE 2: JAPAN ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET, BY THERAPEUTICS AND DIAGNOSTICS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: JAPAN ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET, BY THERAPEUTICS AND DIAGNOSTICS, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 4: JAPAN THERAPEUTICS MARKET, BY DRUGS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: JAPAN THERAPEUTICS MARKET, BY DRUGS, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 6: JAPAN THERAPEUTICS MARKET, BY DISEASE STAGE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: JAPAN THERAPEUTICS MARKET, BY DISEASE STAGE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 8: JAPAN THERAPEUTICS MARKET, BY GENERIC AND BRANDED, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: JAPAN THERAPEUTICS MARKET, BY GENERIC AND BRANDED, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 10: JAPAN DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: JAPAN DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 12: LIST OF MERGERS & ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
TABLE 15: LIST OF BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS